ABSTRACT
Although long-term survival and potential cure after surgical resection has not been demonstrated by randomized controlled trials, the evidence (uniformly poor results observed in untreated patients in contrast to extensive data documenting long-term survival after hepatectomy) supports a significant survival benefit from resection and has provided the rationale for increasing indications for liver surgery as the most effective treatment of CRLM.
